The significant contribution of Dr. Carolyn R. Bertozzi’s work on protein sugars that won her the 2022 Nobel Prize in Chemistry has paved the way to study sugars on cancer cells.
There is a lot to unpack in the deceptively simple (and simply deceptive) 30-minute documentary Infertility: A Diabolical Agenda, released on June 10, 2022. It focuses on the claim that a tetanus vaccination campaign in Kenya was actually a covert operation to use a contraceptive vaccine to permanently rob African women of their fertility.
This article was originally posted in the Montreal Gazette. It beggars belief, but I still sometimes hear people claim that waves of young athletes have died suddenly after being vaccinated. It is a pervasive hoax and still repeated by people to express doubts about the safety of the COVID-19 vaccines. Fortunately, we don’t have to speculate about whether young athletes are dying or not. We ...
There is a lot to unpack in the deceptively simple (and simply deceptive) 30-minute documentary Infertility: A Diabolical Agenda, released on June 10, 2022. Read more about Infertility: A Diabolical Agenda Is Anti-Vaxx Sleight-of-Hand Propaganda
A Future-Proof Coronavirus Vaccine We have tried to do it for the common cold and the flu. Can we create a universal coronavirus vaccine to protect us from future pandemics? Jonathan Jarry M.Sc. | 28 Apr 2022 COVID-19
QAnon’s Adrenochrome Quackery QAnon is a not-so-fringe, baseless theory that a government agent, “Q,” is a source of continuous information about “deep state” secrets such as the existence of a global cabal of pedophiles who thirst for the blood of children. Joe Schwarcz PhD | 10 Feb 2022 Pseudoscience
This is where the third winner of the 2022 Nobel Prize in Chemistry comes in- Carolynn R. Bertozzi. Wanting to study the complex sugars that sit on the surface of certain cells, Bertozzi was inspired by click chemistry’s simple and efficient nature.
In a landmark study (Diabetes Obes Metab. 2022; 24:1553-1564), 1961 obese adults were treated with 2.4 mg of semaglutide (i.e., the same drug in Ozempic, Wegovy and Rybelsus) for 68 weeks, with 327 of the participants followed for an additional year following treatment discontinuation.
A study in 2022 found that patients treated with lithium for bipolar disease had about half the risk of developing Alzheimer’s disease compared with people not receiving such treatment.
